WO2003101437A3 - Method of treating asthma using fexofenadine - Google Patents

Method of treating asthma using fexofenadine Download PDF

Info

Publication number
WO2003101437A3
WO2003101437A3 PCT/US2003/016547 US0316547W WO03101437A3 WO 2003101437 A3 WO2003101437 A3 WO 2003101437A3 US 0316547 W US0316547 W US 0316547W WO 03101437 A3 WO03101437 A3 WO 03101437A3
Authority
WO
WIPO (PCT)
Prior art keywords
fexofenadine
treating asthma
patient
administering
asthma
Prior art date
Application number
PCT/US2003/016547
Other languages
French (fr)
Other versions
WO2003101437A2 (en
Inventor
Ian Davidson
Parviz Hamedani
Steve Offord
Barbara Kittner
Akkad Tarek El
Original Assignee
Aventis Pharmaceuticals Holdin
Ian Davidson
Parviz Hamedani
Steve Offord
Barbara Kittner
Akkad Tarek El
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0221350A external-priority patent/GB0221350D0/en
Application filed by Aventis Pharmaceuticals Holdin, Ian Davidson, Parviz Hamedani, Steve Offord, Barbara Kittner, Akkad Tarek El filed Critical Aventis Pharmaceuticals Holdin
Priority to BR0306329-1A priority Critical patent/BR0306329A/en
Priority to AU2003237253A priority patent/AU2003237253A1/en
Publication of WO2003101437A2 publication Critical patent/WO2003101437A2/en
Publication of WO2003101437A3 publication Critical patent/WO2003101437A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a method of treating mild to moderate asthma in a patient in need thereof comprising administering to said patient a therapeutically effective amount of fexofenadine.
PCT/US2003/016547 2002-05-29 2003-05-27 Method of treating asthma using fexofenadine WO2003101437A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR0306329-1A BR0306329A (en) 2002-05-29 2003-05-27 Asthma Treatment Method
AU2003237253A AU2003237253A1 (en) 2002-05-29 2003-05-27 Method of treating asthma using fexofenadine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38396002P 2002-05-29 2002-05-29
US60/383,960 2002-05-29
GB0221350.2 2002-09-16
GB0221350A GB0221350D0 (en) 2002-05-29 2002-09-16 Method of treating asthma

Publications (2)

Publication Number Publication Date
WO2003101437A2 WO2003101437A2 (en) 2003-12-11
WO2003101437A3 true WO2003101437A3 (en) 2008-01-24

Family

ID=29713396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/016547 WO2003101437A2 (en) 2002-05-29 2003-05-27 Method of treating asthma using fexofenadine

Country Status (3)

Country Link
AU (1) AU2003237253A1 (en)
BR (1) BR0306329A (en)
WO (1) WO2003101437A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008690A1 (en) * 1997-08-14 1999-02-25 Hoechst Marion Roussel, Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
WO1999032125A1 (en) * 1997-12-23 1999-07-01 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
WO1999052554A1 (en) * 1998-04-14 1999-10-21 Sepracor Inc. Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
WO2000021510A2 (en) * 1998-10-13 2000-04-20 West Pharmaceutical Services Drug Delivery & Clinical Research Centre, Ltd. Formulations of fexofenadine
US20010011102A1 (en) * 1998-12-07 2001-08-02 Weinstein Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008690A1 (en) * 1997-08-14 1999-02-25 Hoechst Marion Roussel, Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
WO1999032125A1 (en) * 1997-12-23 1999-07-01 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
WO1999052554A1 (en) * 1998-04-14 1999-10-21 Sepracor Inc. Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
WO2000021510A2 (en) * 1998-10-13 2000-04-20 West Pharmaceutical Services Drug Delivery & Clinical Research Centre, Ltd. Formulations of fexofenadine
US20010011102A1 (en) * 1998-12-07 2001-08-02 Weinstein Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis

Also Published As

Publication number Publication date
BR0306329A (en) 2005-04-26
AU2003237253A8 (en) 2008-03-13
AU2003237253A1 (en) 2003-12-19
WO2003101437A2 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
DE60140693D1 (en) Ankheiten
YU71901A (en) NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS
WO2006036371A3 (en) Combination therapy
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
WO2001030381A3 (en) Use of csf-1 inhibitors
WO2003032914A3 (en) Methods for treating substance abuse with cholinesterase inhibitors
AU2003300791A1 (en) Combination therapy for the treatment of pain
WO2003059270A3 (en) Method for reducing morbidity and mortality in critically ill patients
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
WO2003072048A3 (en) Symptomatic relief of gastrointestinal disorders
WO2004012762A3 (en) Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
WO2002066500A3 (en) ANTAGONISTS FPR Α4β7-INTEGRIN
WO2001087343A3 (en) Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
WO2004028548A3 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
WO2004026228A3 (en) Method for reducing morbidity and mortality in critically ill patients
WO2004028468A3 (en) Methods and compositions for treatment of neurological disorder
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2006079625A3 (en) Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
WO2003101437A3 (en) Method of treating asthma using fexofenadine
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
WO2004105759A3 (en) Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP